Latest posts
-
Biocardia CFO David McClung Invests $24,999 in Company Stock: A Signal of Confidence?
Introduction In recent financial news, David McClung, the Chief Financial Officer (CFO) of Biocardia, made headlines by purchasing company stock worth $24,999. This investment has sparked interest among investors and analysts alike, raising questions about its implications for the organization and its stakeholders. As the CFO, McClung’s decision to personally invest in Biocardia may be…
